Fall Clinical 2025 News: PsO Patients, Providers Would Prefer Pill Over Injectables, Topicals
Fully 50.5% of adult psoriasis patients eligible for systemic therapy and 47.5% of dermatology providers would prefer oral treatment over topicals or injectables, a new survey shows. The ENCOMPASS study is a cross-sectional survey of 400 adults and 200 adolescents with psoriasis and 200 dermatology providers. The findings, which were presented at the 2025 Fall […]